These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 8424551)

  • 21. [4-chloro-m-cresol-induced contractures of skeletal muscle specimen from patients at risk for malignant hyperthermia].
    Wappler F; Scholz J; von Richthofen V; Fiege M; Steinfath M; Schulte am Esch J
    Anasthesiol Intensivmed Notfallmed Schmerzther; 1997 Sep; 32(9):541-8. PubMed ID: 9417254
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Malignant hyperthermia: a disease of specific myofiber type?
    Nelson TE; Schochet SS
    Can Anaesth Soc J; 1982 Mar; 29(2):163-7. PubMed ID: 7066741
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Patients with malignant hyperthermia demonstrate an altered calcium control mechanism in B lymphocytes.
    Sei Y; Brandom BW; Bina S; Hosoi E; Gallagher KL; Wyre HW; Pudimat PA; Holman SJ; Venzon DJ; Daly JW; Muldoon S
    Anesthesiology; 2002 Nov; 97(5):1052-8. PubMed ID: 12411786
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Theophylline induces contractures in porcine skeletal muscle preparations with the disposition to malignant hyperthermia].
    Gerbershagen MU; Fiege M; Weisshorn R; Kolodzie K; Wappler F
    Anasthesiol Intensivmed Notfallmed Schmerzther; 2004 Mar; 39(3):147-52. PubMed ID: 15042504
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of the calcium antagonist, TMB-8 on halothane and on caffeine contractures of malignant hyperthermia susceptible skeletal muscle.
    Williams JH; Holland M; Lee JC
    Res Commun Chem Pathol Pharmacol; 1990 Jun; 68(3):387-90. PubMed ID: 2385762
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Fura-2 detected myoplasmic calcium and its correlation with contracture force in skeletal muscle from normal and malignant hyperthermia susceptible pigs.
    Iaizzo PA; Klein W; Lehmann-Horn F
    Pflugers Arch; 1988 Jun; 411(6):648-53. PubMed ID: 3412868
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Diagnosis of malignant hyperthermia susceptibility. 1. The significance of in vitro susceptibility tests].
    Mortier W; Breucking E
    Anaesthesist; 1993 Oct; 42(10):675-83. PubMed ID: 8250201
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Effects of serotonin 2 receptor agonists on skeletal muscle preparations in patients with a disposition toward malignant hyperthermia].
    Wappler F; Roewer N; Köchling A; Scholz J; Steinfath M; Rumberger E; Löscher W; Schulte am Esch J
    Anaesthesist; 1995 Aug; 44(8):538-44. PubMed ID: 7573901
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [The action of ketamine on muscle contractile behavior. In vitro studies on the musculature of subjects susceptible to malignant hyperthermia].
    Hackl W; Winkler M; Mauritz W; Steinbereithner K
    Anaesthesist; 1989 Dec; 38(12):681-5. PubMed ID: 2619030
    [TBL] [Abstract][Full Text] [Related]  

  • 30. In vitro diagnosis of malignant hyperthermia susceptibility with ryanodine-induced contractures in human skeletal muscles.
    Wappler F; Roewer N; Köchling A; Scholz J; Steinfath M; Schulte am Esch J
    Anesth Analg; 1996 Jun; 82(6):1230-6. PubMed ID: 8638796
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Phosphodiesterase-III-inhibition with amrinone leads to contracture development in skeletal muscle preparations of malignant hyperthermia susceptible swine.
    Fiege M; Wappler F; Weisshorn R; Gerbershagen MU; Kolodzie K; Schulte am Esch J
    Eur J Anaesthesiol; 2005 Apr; 22(4):283-8. PubMed ID: 15892406
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Skeletal muscle excitation-contraction coupling. I. Transverse tubule control of peeled fiber Ca2+-induced Ca2+ release in normal and malignant hyperthermic muscles.
    Donaldson SK; Gallant EM; Huetteman DA
    Pflugers Arch; 1989 May; 414(1):15-23. PubMed ID: 2726433
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ca-induced Ca release in malignant hyperthermia-susceptible pig skeletal muscle.
    Ohta T; Endo M; Nakano T; Morohoshi Y; Wanikawa K; Ohga A
    Am J Physiol; 1989 Feb; 256(2 Pt 1):C358-67. PubMed ID: 2919663
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Propofol is a 'safe' anaesthetic agent in malignant hyperthermia susceptible patients.
    McKenzie AJ; Couchman KG; Pollock N
    Anaesth Intensive Care; 1992 May; 20(2):165-8. PubMed ID: 1595850
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Intramuscular injection of malignant hyperthermia trigger agents induces hypermetabolism in susceptible and nonsusceptible individuals.
    Metterlein T; Schuster F; Kranke P; Roewer N; Anetseder M
    Eur J Anaesthesiol; 2010 Jan; 27(1):77-82. PubMed ID: 19809329
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cystathionine β-synthase-derived hydrogen sulfide is involved in human malignant hyperthermia.
    Vellecco V; Mancini A; Ianaro A; Calderone V; Attanasio C; Cantalupo A; Andria B; Savoia G; Panza E; Di Martino A; Cirino G; Bucci M
    Clin Sci (Lond); 2016 Jan; 130(1):35-44. PubMed ID: 26460077
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Histological support for the difference between malignant hyperthermia susceptible (MHS), equivocal (MHE) and negative (MHN) muscle biopsies.
    Mezin P; Payen JF; Bosson JL; Brambilla E; Stieglitz P
    Br J Anaesth; 1997 Sep; 79(3):327-31. PubMed ID: 9389850
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Effect of chlorocresol vs caffeine on muscle contracture in malignant hyperthermia susceptible patients].
    Ben-Abraham R; Krivosic-Horber RM; Haudcoeur G; Perel A; Adnet PJ
    Harefuah; 1997 Jun; 132(12):839-41, 911. PubMed ID: 9264187
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Malignant hyperthermia and related neuromuscular diseases: caffeine contracture of the skinned muscle fibers.
    Takagi A; Sunohara N; Ishihara T; Nonaka I; Sugita H
    Muscle Nerve; 1983 Sep; 6(7):510-4. PubMed ID: 6633564
    [TBL] [Abstract][Full Text] [Related]  

  • 40. An in-vivo metabolic test for detecting malignant hyperthermia susceptibility in humans: a pilot study.
    Schuster F; Metterlein T; Negele S; Kranke P; Muellenbach RM; Schwemmer U; Roewer N; Anetseder M
    Anesth Analg; 2008 Sep; 107(3):909-14. PubMed ID: 18713904
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.